Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recruitment of FBXO22 for targeted degradation of NSD2.
Nie DY, Tabor JR, Li J, Kutera M, St-Germain J, Hanley RP, Wolf E, Paulakonis E, Kenney TMG, Duan S, Shrestha S, Owens DDG, Maitland MER, Pon A, Szewczyk M, Lamberto AJ, Menes M, Li F, Penn LZ, Barsyte-Lovejoy D, Brown NG, Barsotti AM, Stamford AW, Collins JL, Wilson DJ, Raught B, Licht JD, James LI, Arrowsmith CH. Nie DY, et al. Among authors: collins jl. Nat Chem Biol. 2024 Jul 4. doi: 10.1038/s41589-024-01660-y. Online ahead of print. Nat Chem Biol. 2024. PMID: 38965384
Recruitment of FBXO22 for Targeted Degradation of NSD2.
Nie DY, Tabor JR, Li J, Kutera M, St-Germain J, Hanley RP, Wolf E, Paulakonis E, Kenney TMG, Duan S, Shrestha S, Owens DDG, Pon A, Szewczyk M, Lamberto AJ, Menes M, Li F, Barsyte-Lovejoy D, Brown NG, Barsotti AM, Stamford AW, Collins JL, Wilson DJ, Raught B, Licht JD, James LI, Arrowsmith CH. Nie DY, et al. Among authors: collins jl. bioRxiv [Preprint]. 2023 Nov 30:2023.11.01.564830. doi: 10.1101/2023.11.01.564830. bioRxiv. 2023. Update in: Nat Chem Biol. 2024 Jul 4. doi: 10.1038/s41589-024-01660-y. PMID: 37961297 Free PMC article. Updated. Preprint.
Ube3a unsilencer for the potential treatment of Angelman syndrome.
Vihma H, Li K, Welton-Arndt A, Smith AL, Bettadapur KR, Gilmore RB, Gao E, Cotney JL, Huang HC, Collins JL, Chamberlain SJ, Lee HM, Aubé J, Philpot BD. Vihma H, et al. Among authors: collins jl. Nat Commun. 2024 Jul 8;15(1):5558. doi: 10.1038/s41467-024-49788-8. Nat Commun. 2024. PMID: 38977672 Free PMC article.
P-Glycoprotein and Breast Cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects.
Bhardwaj R, Collins JL, Stringfellow J, Madonia J, Anderson MS, Finley JA, Stock DA, Coric V, Croop R, Bertz R. Bhardwaj R, et al. Among authors: collins jl. Clin Pharmacol Drug Dev. 2022 Jul;11(7):889-897. doi: 10.1002/cpdd.1088. Epub 2022 Mar 19. Clin Pharmacol Drug Dev. 2022. PMID: 35304977 Free PMC article. Clinical Trial.
280 results